Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$396K Sell
2,042
-10
-0.5% -$2.02K 0.01% 325
2021
Q2
$382K Buy
2,052
+3
+0.1% +$521 0.01% 330
2021
Q1
$323K Buy
2,049
+15
+0.7% +$2.38K 0.01% 323
2020
Q4
$337K Buy
2,034
+581
+40% +$94.5K 0.01% 307
2020
Q3
$240K Sell
1,453
-43
-3% -$6.61K 0.01% 295
2020
Q2
$205K Buy
+1,496
New +$195K 0.01% 298
2020
Q1
Sell
-2,919
Closed -$386K 370
2019
Q4
$386K Sell
2,919
-166
-5% -$20.6K 0.02% 257
2019
Q3
$384K Sell
3,085
-92
-3% -$11.1K 0.02% 249
2019
Q2
$361K Buy
3,177
+40
+1% +$4.19K 0.02% 261
2019
Q1
$316K Buy
3,137
+126
+4% +$11.4K 0.02% 262
2018
Q4
$258K Buy
3,011
+61
+2% +$5.49K 0.02% 255
2018
Q3
$270K Buy
+2,950
New +$262K 0.02% 274

Other funds holding ZTS

Homrich & Berg's ZTS Position: Q3 2021 in Review

Homrich & Berg reduced its Zoetis (ZTS) stake by 0.49% in Q3 2021, selling an estimated $2.02K and leaving 2,042 shares worth $396K. The position accounts for 0.01% of the portfolio, ranked #325.

Homrich & Berg first reported a position in ZTS in Q3 2018 and has held it in 12 quarters since. 1,477 funds tracked by Wall St. Rank hold ZTS as of Q3 2021.

  • Homrich & Berg held 2,042 shares of Zoetis worth $396K as of Q3 2021.
  • Homrich & Berg sold 10 Zoetis shares in Q3 2021, an estimated $2.02K.
  • Zoetis made up 0.01% of Homrich & Berg's portfolio in Q3 2021, its #325 holding.
  • Homrich & Berg first reported a position in Zoetis in Q3 2018 and has held it in 12 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Zoetis as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.